Investigation of Mifepristone (RU486) on Stress Sensitivity and Relapse Prevention in Cocaine Dependent Patients
Status:
Completed
Trial end date:
2018-02-14
Target enrollment:
Participant gender:
Summary
This research will evaluate the impact of blocking central and peripheral glucocorticoid
receptors on stress sensitivity and the risk of relapse to cocaine use in treatment-seeking
cocaine-dependent individuals. Mifepristone (RU-486) will be the glucocorticoid antagonist
used.